eXoZymes Reports Third Quarter Financial Results
eXoZymes (EXOZ) has released its third-quarter financial results, reporting a net loss of $2.24 million for the period. This figure includes a non-cash gain of $0.77 million resulting from changes in the fair value of warrant liabilities. The company's cumulative nine-month net loss currently stands at $7.49 million. Operating expenses saw an increase of 21.0% year-over-year, rising to $3.05 million compared to $2.52 million in the same period last year. These results reflect ongoing expenditure increases as the company continues its operations.
